High-dose methylprednisolone inhibits the OKT3-induced cytokine-related syndrome.
Peces
R
R
Urra
J M
JM
Escalada
P
P
Gorostidi
M
M
González
E
E
López-Larrea
C
C
D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004417:Dyspnea / Q000139:chemically induced / Q000517:prevention & control*; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000517:prevention & control*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D011654:Pulmonary Edema / Q000139:chemically induced / Q000517:prevention & control*; D013577:Syndrome
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D008775:Methylprednisolone